Literature DB >> 30201422

Alpha-synuclein and the prion hypothesis in Parkinson's disease.

R Melki1.   

Abstract

Protein intracellular inclusions within the central nervous system are hallmarks of several progressive neurodegenerative disorders in man. The protein constituents of those deposits and the affected regions within the brain differ from one neurodegenerative disorder to another. Until recently, the vicious circle consisting of spread, seeded assembly and accumulation over time within the central nervous system of misfolded proteins aggregates was thought to be restricted to the prion protein PrP. Recent reports suggest that other protein aggregates spread and amplify within the central nervous system leading to distinct diseases. How alpha-synuclein protein assemblies traffic between cells, amplify by recruiting endogenous monomeric alpha-synuclein and cause distinct synucleinopathies is unclear. I review here the experimental evidence supporting the propagation of alpha-synuclein mega-dalton assemblies in a manner similar to prion protein aggregates. I also describe how alpha-synuclein aggregates. I also explain why the aggregation of alpha-synuclein may lead to distinct synucleinopathies.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Dementia with Lewy bodies; Multiple system atrophy; Parkinson's disease; prion-like propagation

Mesh:

Substances:

Year:  2018        PMID: 30201422     DOI: 10.1016/j.neurol.2018.08.002

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  6 in total

1.  Binding Stability of Antibody-α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein Antibodies.

Authors:  Matthias Höllerhage; Andreas Wolff; Tasnim Chakroun; Valentin Evsyukov; Linghan Duan; Oscar Wing-Ho Chua; Qilin Tang; Thomas Koeglsperger; Günter U Höglinger
Journal:  Mol Neurobiol       Date:  2022-04-22       Impact factor: 5.682

2.  NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP.

Authors:  Ying Chen; Qiu-Shuang Zhang; Qian-Hang Shao; Shuo Wang; Yu-He Yuan; Nai-Hong Chen; Hong-Bo Wang
Journal:  Acta Pharmacol Sin       Date:  2019-02-06       Impact factor: 6.150

3.  Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus.

Authors:  Hannah Bender; Simone A Fietz; Franziska Richter; Milos Stanojlovic
Journal:  Front Cell Dev Biol       Date:  2021-07-07

4.  Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.

Authors:  Changyoun Kim; Armine Hovakimyan; Karen Zagorski; Tatevik Antonyan; Irina Petrushina; Hayk Davtyan; Gor Chailyan; Jonathan Hasselmann; Michiyo Iba; Anthony Adame; Edward Rockenstein; Marcell Szabo; Mathew Blurton-Jones; David H Cribbs; Anahit Ghochikyan; Eliezer Masliah; Michael G Agadjanyan
Journal:  NPJ Vaccines       Date:  2022-01-10       Impact factor: 7.344

5.  Conformation-Dependent Influences of Hydrophobic Amino Acids in Two In-Register Parallel β-Sheet Amyloids, an α-Synuclein Amyloid and a Local Structural Model of PrPSc.

Authors:  Hiroki Otaki; Yuzuru Taguchi; Noriyuki Nishida
Journal:  ACS Omega       Date:  2022-08-24

6.  Blood-Derived α-Synuclein Aggregated in the Substantia Nigra of Parabiotic Mice.

Authors:  Xizhen Ma; Leilei Chen; Ning Song; Le Qu; Jun Wang; Junxia Xie
Journal:  Biomolecules       Date:  2021-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.